BioSpace News Archive

Bebe Rexha, JoJo, RaeLynn & Ozomatli Perform in Honor of JDRF’s 50th Anniversary and 50 Years of T1D Breakthroughs Hosted by KTLA’s Frank Buckley

MEMPHIS, Tenn., June 30, 2020 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services, LLC (“CPS”), through its SPARx SM service offering, proudly announces its new accreditation through the Accreditation Commission for Health Care (ACHC) for its Patient Care Services. Accreditation is a process through which healthcare organizations demonstrate their compliance with national standards. Accreditation by ACHC reflects SPARx Patient Care Services’ dedication and commitment to meeting standards that

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins, announced that it has enrolled its first patients in the NASH-RX trial.

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, was added to the US small-cap Russell 2000® Index during the 2020 Russell Indexes reconstitution, effective after the US market close on June 26 th . Membership in the Russell 2000® Index, which remains in place for at least one year, is based on membership in the broad-market

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announced today its inclusion in the “S&P/BMV Total Mexico ESG Index”. The new ESG index was launched on June 22, 2020

− Long-Term Givosiran Dosing Showed Sustained Reduction in Annualized Rate of Composite Porphyria Attacks (AAR) With a Median AAR of Zero and Over 60 Percent of Patients Attack-Free in the Open-Label Extension Period − − Safety Profile Consistent With That Observed in the 6-Month Double-Blind Period, With No New Safety Findings − CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeuti

Sinclair Research, a leading provider of nonclinical contract research services, today announced completion of successful validation of GLP ototoxicity testing services in partnership with Turner Scientific, an industry leader specializing in nonclinical hearing research. “Sinclair’s validated GLP ototoxicity testing services provide drug developers with more research options,” Andy Brown, Sinclair Research’s Vice Presi

Iterum Therapeutics plc announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 3,372,686 of its ordinary shares at a purchase price of $1.4825 per ordinary share in a registered direct offering priced at-the-market under Nasdaq rules.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced entering into a sponsored research agreement with Virginia Commonwealth University (VCU) for a potential COVID-19 treatment.

Ambu Inc., a rapidly growing pioneer of sterile, single-use medical devices, and Fuel Medical Group, the leading business advisory resource for ENTs, audiologists, otologists and universities, have entered into a partnership the companies announced today. Under the agreement, Ambu will offer Fuel Medical entrée to a broad hospital market for services, including marketing, finance, digital strategies, professional deve